Growth differentiation factor 11 attenuates sepsis-associated acute kidney injury by reducing inflammation and coagulation via PGC-1α/Nrf2 activation.

Saved in:
Bibliographic Details
Title: Growth differentiation factor 11 attenuates sepsis-associated acute kidney injury by reducing inflammation and coagulation via PGC-1α/Nrf2 activation.
Authors: Wang HW; Zhejiang Key Laboratory of Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China., Wu MM; Zhejiang Key Laboratory of Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China., Zhu MM; Department of Pediatrics, The First Affiliated Hospital of Wenzhou Medical University, No. 322 Nanbaixiang Street, Wenzhou, 325000, Zhejiang, China., Qin YY; Department of Pediatrics, The First Affiliated Hospital of Wenzhou Medical University, No. 322 Nanbaixiang Street, Wenzhou, 325000, Zhejiang, China., Wang KQ; Department of Pediatrics, The First Affiliated Hospital of Wenzhou Medical University, No. 322 Nanbaixiang Street, Wenzhou, 325000, Zhejiang, China., Wu CY; Department of Pediatrics, The First Affiliated Hospital of Wenzhou Medical University, No. 322 Nanbaixiang Street, Wenzhou, 325000, Zhejiang, China., Zhang RR; Cixi Biomedical Research Institute, Wenzhou Medical University, Zhejiang, 315300, China., Wang Y; Cixi Biomedical Research Institute, Wenzhou Medical University, Zhejiang, 315300, China., Zhou C; Department of Intensive Care Unit, The First Affiliated Hospital of Wenzhou Medical University, No. 322 Nanbaixiang Street, Wenzhou, 325000, Zhejiang, China., Luo S; Department of Intensive Care Unit, The First Affiliated Hospital of Wenzhou Medical University, No. 322 Nanbaixiang Street, Wenzhou, 325000, Zhejiang, China., Lu CS; Department of Pediatrics, The First Affiliated Hospital of Wenzhou Medical University, No. 322 Nanbaixiang Street, Wenzhou, 325000, Zhejiang, China. lucs363@163.com.; Zhejiang Provincial Clinical Research Center for Pediatric Disease, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China. lucs363@163.com., Pan JY; Zhejiang Key Laboratory of Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China. panjingye@wmu.edu.cn.; Cixi Biomedical Research Institute, Wenzhou Medical University, Zhejiang, 315300, China. panjingye@wmu.edu.cn.; Department of Intensive Care Unit, The First Affiliated Hospital of Wenzhou Medical University, No. 322 Nanbaixiang Street, Wenzhou, 325000, Zhejiang, China. panjingye@wmu.edu.cn.
Source: Cellular & molecular biology letters [Cell Mol Biol Lett] 2025 Aug 28; Vol. 30 (1), pp. 102. Date of Electronic Publication: 2025 Aug 28.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 9607427 Publication Model: Electronic Cited Medium: Internet ISSN: 1689-1392 (Electronic) Linking ISSN: 14258153 NLM ISO Abbreviation: Cell Mol Biol Lett Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1689-1392
DOI:10.1186/s11658-025-00762-2